Infiltration and extravasation.
暂无分享,去创建一个
[1] K. So,et al. The Use of Hyaluronidase for Treatment of Extravasations in a Premature Infant , 2007 .
[2] A. Shamseddine,et al. Dexrazoxane for anthracycline extravasation and GM-CSF for skin ulceration and wound healing. , 2004, The Lancet. Oncology.
[3] J. Hankins.... Infusion therapy in clinical practice , 2001 .
[4] W. V. van Vloten,et al. Localized bullous eruptions caused by extravasation of commonly used intravenous infusion fluids. , 1991, Dermatologica.
[5] S. Phelps,et al. Risk factors affecting infiltration of peripheral venous lines in infants. , 1987, The Journal of pediatrics.
[6] S. Langer,et al. DEXRAZOXANE - A PROMISING ANTIDOTE IN THE TREATMENT OF ACCIDENTAL EXTRAVASATION OF ANTHRACYCLINES , 2003, Scandinavian journal of plastic and reconstructive surgery and hand surgery.
[7] W. Akeson,et al. Hyperbaric oxygen reduces edema and necrosis of skeletal muscle in compartment syndromes associated with hemorrhagic hypotension. , 1986, The Journal of bone and joint surgery. American volume.
[8] W. Raszka,et al. The use of hyaluronidase in the treatment of intravenous extravasation injuries. , 1990, Journal of perinatology : official journal of the California Perinatal Association.
[9] F. A. Matsen,et al. Fasciotomy in the treatment of the acute compartment syndrome. , 1976, The Journal of bone and joint surgery. American volume.
[10] J. Truchot. 8 – Regulation of Acid—Base Balance , 1983 .
[11] D. Alberts,et al. Vinca alkaloid skin toxicity: antidote and drug disposition studies in the mouse. , 1985, Journal of the National Cancer Institute.
[12] P. Cronier,et al. Hyperbaric oxygen therapy in the management of crush injuries: a randomized double-blind placebo-controlled clinical trial. , 1996, The Journal of trauma.
[13] G. Bertelli,et al. Hyaluronidase as an antidote to extravasation ofVinca alkaloids: Clinical results , 2005, Journal of Cancer Research and Clinical Oncology.
[14] Bass Jw,et al. The use of hyaluronidase in the treatment of intravenous extravasation injuries. , 1990 .
[15] R. Cohan,et al. Extravasation of nonionic radiologic contrast media: efficacy of conservative treatment. , 1990, Radiology.
[16] D Camp-Sorrell,et al. Developing extravasation protocols and monitoring outcomes. , 1998, Journal of intravenous nursing : the official publication of the Intravenous Nurses Society.
[17] G. Rayan,et al. Intravenous catheter complications in the hand and forearm. , 2004, The Journal of trauma.
[18] Y. Sako,et al. Pedal gangrene associated with the use of dopamine. , 1975, The New England journal of medicine.
[19] L. A. Montgomery,et al. Guideline for i.v. infiltrations in pediatric patients. , 1999, Pediatric nursing.
[20] A. Toklu,et al. Hyperbaric Oxygen Therapy in Adriamycin Extravasation: An Experimental Animal Study , 2000, Annals of plastic surgery.
[21] R. Giunta. Early subcutaneous wash-out in acute extravasations. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.
[22] G. Schears. Summary of Product Trials for 10, 164 Patients: Comparing an Intravenous Stabilizing Device to Tape , 2006, Journal of infusion nursing : the official publication of the Infusion Nurses Society.
[23] B. L. Gahart,et al. Intravenous Medications: A Handbook for Nurses and Allied Health Professionals , 1977 .
[24] N. Szeverenyi,et al. Effect of warm and cold applications on the resolution of i.v. infiltrations. , 1993, Research in nursing & health.
[25] S. B. Moody,et al. Treatment of Peripheral Ischemia Secondary to Lidocaine Containing Epinephrine , 1989, Annals of plastic surgery.
[26] D. Larson. Treatment of tissue extravasation by antitumor agents , 1982, Cancer.
[27] Linda Duncan,et al. Infusion Nursing: Aspects of Practice Liability , 2007, Journal of infusion nursing : the official publication of the Infusion Nurses Society.
[28] G. Zucker. Use of phentolamine to prevent necrosis due to levarterenol. , 1957, Journal of the American Medical Association.
[29] R. Dorr,et al. Mitomycin C skin toxicity studies in mice: reduced ulceration and altered pharmacokinetics with topical dimethyl sulfoxide. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] R. Dorr,et al. Antidotes to vesicant chemotherapy extravasations. , 1990, Blood reviews.
[31] G. Greene,et al. Nafcillin extravasation injury. Use of hyaluronidase as an antidote. , 1981, American journal of diseases of children.
[32] R. Wickham,et al. Vesicant extravasation part II: Evidence-based management and continuing controversies. , 2006, Oncology nursing forum.
[33] P. Willemse,et al. A new conservative approach to extravasation of anthracyclines with dimethylsulfoxide and dexrazoxane. , 2001, Acta oncologica.
[34] N. J. Bush. Mitoxantrone-induced extravasation. , 2005 .
[35] O. Garrone,et al. Topical dimethylsulfoxide for the prevention of soft tissue injury after extravasation of vesicant cytotoxic drugs: a prospective clinical study. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[36] R. Kaplan,et al. A prospective study of topical dimethyl sulfoxide for treating anthracycline extravasation. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[37] N. Scuderi,et al. Antitumor Agents: Extravasation, Management, and Surgical Treatment , 1994, Annals of plastic surgery.
[38] G. Bertelli. Prevention and Management of Extravasation of Cytotoxic Drugs , 1995, Drug safety.
[39] E. Woltering,et al. DMSO protects against adriamycin-induced tissue necrosis. , 1992, The Journal of surgical research.
[40] D. Larson,et al. Etiology and treatment of chemotherapeutic agent extravasation injuries: a review. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[41] A. Hargens,et al. Acute compartment syndromes. , 1983, The Surgical clinics of North America.
[42] J. Mulliken,et al. Major intravenous extravasation injuries. , 1979, American journal of surgery.
[43] W. Akeson,et al. Reduction of skeletal muscle necrosis using intermittent hyperbaric oxygen in a model compartment syndrome. , 1983, The Journal of bone and joint surgery. American volume.
[44] D. Redelmeier,et al. Adhesive tape and intravascular-catheter-associated infections , 1999, Journal of General Internal Medicine.
[45] C. Akman,et al. Intrathoracic Extravasation of Antineoplastic Agents: Case Report and Systematic Review , 2003, American journal of clinical oncology.
[46] S. Langer. Dexrazoxane for anthracycline extravasation , 2000, Expert review of anticancer therapy.
[47] F. Lombardo,et al. Extravasation of chemotherapeutic agents: prevention and treatment. , 2006, Seminars in oncology.
[48] D. Schrijvers. Extravasation: a dreaded complication of chemotherapy. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.
[49] Js Gregory. Statlock catheter securement device significantly reduces central venous catheter complications , 2000 .
[50] R. Wickham,et al. Vesicant extravasation part I: Mechanisms, pathogenesis, and nursing care to reduce risk. , 2006, Oncology nursing forum.
[51] H. Langstein,et al. Retrospective Study of the Management of Chemotherapeutic Extravasation Injury , 2002, Annals of plastic surgery.
[52] T. Kuwahara,et al. Experimental infusion phlebitis: tolerance pH of peripheral vein. , 1999, The Journal of toxicological sciences.
[53] D. Louis,et al. Complex regional pain syndrome type I in the upper extremity. , 2006, Clinics in occupational and environmental medicine.
[54] C. Langlotz,et al. Contrast media reactions and extravasation: relationship to intravenous injection rates. , 1998, Radiology.
[55] N. Szeverenyi,et al. Effect of elevation on intravenous extravasations. , 1994, Journal of intravenous nursing : the official publication of the Intravenous Nurses Society.
[56] H. Thomsen,et al. Contrast medium extravasation injury: guidelines for prevention and management , 2002, European Radiology.
[57] J. Pettit,et al. Intravenous extravasation: Mechanisms, management, and prevention , 1993 .
[58] D. Alberts,et al. Failure of DMSO and vitamin E to prevent doxorubicin skin ulceration in the mouse. , 1983, Cancer treatment reports.
[59] M. Sehested,et al. Dexrazoxane is a potent and specific inhibitor of anthracycline induced subcutaneous lesions in mice. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.
[60] O. Bayer,et al. Extravasation injury in the perioperative setting. , 2005, Anesthesia and analgesia.
[61] M. Sehested,et al. Treatment of anthracycline extravasation with dexrazoxane. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[62] T. Milward,et al. Severe extravasation injury: an avoidable iatrogenic disaster? , 1985, British medical journal.
[63] S. Kahn,et al. The epidemiology of peripheral vein infusion thrombophlebitis: a critical review. , 2002, The American journal of medicine.
[64] N. Gaze. TISSUE NECROSIS CAUSED BY COMMONLY USED INTRAVENOUS INFUSIONS , 1978, The Lancet.
[65] J. Disa,et al. Prevention of Adriamycin‐Induced Full‐Thickness Skin Loss Using Hyaluronidase Infiltration , 1998, Plastic and reconstructive surgery.
[66] M. Sehested,et al. Treatment of anthracycline extravasation in mice with dexrazoxane with or without DMSO and hydrocortisone , 2005, Cancer Chemotherapy and Pharmacology.
[67] Derek W Liau. Injuries and Liability Related to Peripheral Catheters: A Closed Claims Analysis , 2006 .
[68] M. Friedman,et al. Therapy of local toxicities caused by extravasation of cancer chemotherapeutic drugs. , 1980, Cancer treatment reviews.
[69] M. Styler,et al. Extravasation of systemic hemato-oncological therapies. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.
[70] D. Wood. A comparative study of two securement techniques for short peripheral intravenous catheters. , 1997, Journal of intravenous nursing : the official publication of the Intravenous Nurses Society.
[71] C. Engelking,et al. Vesicant extravasation: myths and realities. , 1995, Oncology nursing forum.
[72] M. O’Sullivan,et al. Outcome of compartment syndrome following intramedullary nailing of tibial diaphyseal fractures. , 2001, Injury.
[73] T. Kuwahara,et al. Experimental infusion phlebitis: tolerance osmolality of peripheral venous endothelial cells. , 1998, Nutrition.
[74] F. Heckler. Current thoughts on extravasation injuries. , 1989, Clinics in plastic surgery.
[75] L. Schulmeister,et al. Chemotherapy extravasation from implanted ports. , 2000, Oncology nursing forum.
[76] G. Giaccone,et al. Treatment of anthracycline extravasation with Savene (dexrazoxane): results from two prospective clinical multicentre studies. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.
[77] P. Saip,et al. Totally implantable venous-access ports: local problems and extravasation injury. , 2002, The Lancet. Oncology.
[78] E Kassner,et al. Evaluation and Treatment of Chemotherapy Extravasation Injuries , 2000, Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses.
[79] G. Hamilton,et al. Acute compartment syndromes , 2002, The British journal of surgery.
[80] S F Viegas,et al. Causes of upper extremity compartment syndrome. , 1998, Hand clinics.
[81] H. Stoll,et al. Prevention of cytotoxic drug induced skin ulcers with dimethyl sulfoxide (DMSO) and α-tocopherole , 1987 .
[82] R. Dorr,et al. Cutaneous ulceration due to contrast extravasation. Experimental assessment of injury and potential antidotes. , 1991, Investigative radiology.
[83] L. Hadaway,et al. The diverse and conflicting standards and practices in infusion therapy. , 2002 .
[84] R. Peterfreund,et al. Compartment syndrome of the upper arm after pressurized infiltration of intravenous fluid. , 1997, Journal of clinical anesthesia.
[85] K. O'Connor,et al. A prospective study of two intravenous catheter securement techniques in a skilled nursing facility. , 1999, Journal of intravenous nursing : the official publication of the Intravenous Nurses Society.
[86] J. Chan,et al. A pediatric protocol for management of extravasation injuries. , 1993, Pediatric nursing.
[87] Krishna Shankara Narayanan,et al. Hyperbaric Oxygen Therapy and Free Radical Production: An Experimental Study in Doxorubicin (Adriamycin) Extravasation Injuries , 1997, Annals of plastic surgery.
[88] M. Ringer,et al. Risk factors for infusion-related phlebitis with small peripheral venous catheters. A randomized controlled trial. , 1991, Annals of internal medicine.